Gland Pharma IPO GMP Today, Gland Pharma IPO Grey Market Premium Updates

Gland Pharma IPO GMP Today, Gland Pharma IPO Grey Market Premium Updates | Gland Pharma IPO Listing Gain, Latest target, Opening gain.

Hyderabad-based Gland Pharma is set to launch its maiden initial public offer on November 9 to raise about Rs 6,500 crore. The price band for the offer has been fixed at Rs 1,490-1,500 per share. The issue will close on 11 November.

The Gland Pharma IPO, India’s largest IPO in the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an offer for sale of up to 3.49 crore shares.

Check out the latest Gland Pharma IPO GMP (Grey Market Premium), Kostak rates and Subject to Sauda rates here.

Gland Pharma IPO Details:

Issuer Gland Pharma Ltd.
Issue Type Book Built Issue IPO
Issue Period Issue Opens: November 9, 2020
Issue Closes: November 11, 2020
Price Brand ₹1490 – 1500 Equity share
Issue Size ₹6500 Crores (Approx.)
Face Value Rs.1 per Equity Share
Market Lot 10 Shares and in multiples thereof
Maximum Bid amount for Retail Rs. 2 Lakhs
QIB 50% of the issue size
NIB 15% of the issue size
Retail Individual Bidders 35% of the issue size
Offer for Sale 34,863,635 shares
(INR5,194.68 – 5,229.55 crore)
Fresh Issue ₹1250 Cr (Expected)
Listing at NSE & BSE
Apply With Upstox Free DEMAT Account
RailTel IPO GMP Today  
Grey Market Price Latest IPO GMP

Gland Pharma IPO Listing

Gland Pharma IPO GMP Rates day by day

Date GMP (in INR) Kostak (in INR) Subject to Sauda
20 Nov 2020      
19 Nov 2020 140 1000 500
18 Nov 2020 140 1000 N/A
17 Nov 2020 70 N/A N/A
16 Nov 2020 50 N/A N/A
15 Nov 2020 10 N/A N/A
14 Nov 2020 10 N/A N/A
13 Nov 2020 10 N/A N/A
12 Nov 2020 20 N/A N/A
11 Nov 2020 25 200 N/A
10 Nov 2020 25 200 N/A
9 Nov 2020 70 500 2000
8 Nov 2020 70 500 2000
6 Nov 2020 70 500 2000
5 Nov 2020 80 500 1,000
4 Nov 2020 170 800 1,200
3 Nov 2020 160 700 1,100
2 Nov 2020 150 700 1,100

Gland Pharma IPO Market Lot:

 Lot Size:  Minimum 10 Shares & Maximum 130 Shares
 Minimum Amount:  ₹15,000
 Maximum Amount:  ₹1,95,000

Gland Pharma IPO Review

Gland Pharma IPO Allotment & Listing:

 Basis of Allotment:  November 17, 2020
 Refunds:  November 18, 2020
 Credit to Demat Account:  November 19, 2020
 Listing Date:  November 20,2020


– IPO Grey Market Premium (IPO GMP) mention is valid for the specific date as mentioned in the header.
– We are not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies

IPO GMP rates are provided as sourced from market intelligence. Please note these IPO GMP rates may be different depending on geographies and markets.

We don’t trade into grey market nor do we facilitate buying or selling of IPO forms.


What is Grey Market?

Grey Market is the term used to describe unregulated over-the-counter market for trading IPO applications and IPO shares before the stock is listed at a stock market. This is a way for dealers to support their customers who may want to exit before listing.

This is also a way to boost the listing price and support the issue before listing happens. There are two kinds of transactions that happen in thee IPO grey market:

  • Trade of IPO shares at a grey market premium
  • Trade of IPO application at a kostak.

What is Grey Market Premium?

GMP or Grey Market Premium is the premium at which equity shares from the IPO are being traded in the grey market.

This could either be a positive or negative – meaning the trading price in the grey market is either higher or lower than issue price respectively, based on demand and supply for the shares.

Typically, investors who do not want to take the risk of allocation not happening through IPO will buy shares in the gray market and hope to flip the shares on listing to make a good profit.

What is Kostak?

Kostak is the premium at which IPO application is being traded in the grey market. Applications are typically traded after the application window is closed but the allotment has not yet been finished.

It is rare for someone to trade IPO application post-allocation. This is a way for investors to increase their chance of shares being allotted as the allocation process treats each retail application equally. An example (indicative) for kostak is:

– IGL Limited
– Issue Price: Rs 480 Per Equity Share (at upper band)
– Lot Size: 14
– Grey Market Premium: Rs 350 to Rs 360
– Kostak (Rs 100000): Rs 2500 to Rs 2600

As can be seen the Kostak is at a much lower %age than GMP. This indicates that the grey market expects the issue to be oversubscribed and expects on an average only one lot to be allocated per application.

Kostak rate is the amount an investor gets by selling his/her IPO application in grey market. This is the amount an investor stands to gain, irrespective of allotment status.

Subject to Sauda simply reflects the amount which an investor stands to get by selling his/her application for firm allotment. The key operative word here is firm allotment. In case of no allotment to the applicant, the sauda stands cancelled.

In case of ‘Subject to Sauda’ deal, while selling IPO application in the grey market, buyer and seller agree that deal is only valid if the seller will get the allotment. If the seller doesn’t get any shares in IPO process, the deal gets avoid.


What is the Grey Market Premium (GMP) price of Gland Pharma Limited IPO?

The Grey Market Premium of Gland Pharma IPO is approx in between Rs.1500 – 2000/- at the moment.

What is the Subject to Sauda price for Gland Pharma IPO?

The Subject to Sauda price for Gland Pharma IPO is approx. Rs. 1200/-

How much will be listing gain in Gland Pharma IPO?

It will be approx. Rs.2500/- (update on a daily basis)

What is kostak price of Gland Pharma IPO?

The Kostak price of Gland Pharma IPO is approx. Rs 800/-.